Gabelli Funds LLC Sells 2,000 Shares of Integer Holdings Co. (NYSE:ITGR)

Gabelli Funds LLC lowered its position in Integer Holdings Co. (NYSE:ITGR) by 1.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 120,871 shares of the medical equipment provider’s stock after selling 2,000 shares during the period. Gabelli Funds LLC’s holdings in Integer were worth $10,710,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Credit Suisse AG grew its holdings in shares of Integer by 8.9% in the first quarter. Credit Suisse AG now owns 40,989 shares of the medical equipment provider’s stock worth $3,177,000 after acquiring an additional 3,342 shares during the period. Louisiana State Employees Retirement System grew its holdings in Integer by 13.6% during the second quarter. Louisiana State Employees Retirement System now owns 17,500 shares of the medical equipment provider’s stock valued at $1,551,000 after purchasing an additional 2,100 shares during the period. SG Capital Management LLC bought a new stake in Integer during the first quarter valued at about $5,426,000. Keybank National Association OH grew its holdings in Integer by 3.8% during the second quarter. Keybank National Association OH now owns 6,487 shares of the medical equipment provider’s stock valued at $575,000 after purchasing an additional 235 shares during the period. Finally, Texas Permanent School Fund Corp grew its holdings in Integer by 33.4% during the first quarter. Texas Permanent School Fund Corp now owns 29,712 shares of the medical equipment provider’s stock valued at $2,303,000 after purchasing an additional 7,438 shares during the period. Institutional investors own 99.29% of the company’s stock.

Insider Activity

In other news, Director Donald J. Spence sold 6,500 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $82.32, for a total transaction of $535,080.00. Following the transaction, the director now owns 18,781 shares of the company’s stock, valued at $1,546,051.92. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.84% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. TheStreet raised Integer from a “c+” rating to a “b” rating in a report on Thursday, July 27th. Wells Fargo & Company boosted their price objective on Integer from $87.00 to $94.00 and gave the company an “equal weight” rating in a research report on Friday, July 28th. KeyCorp boosted their price objective on Integer from $96.00 to $105.00 and gave the company an “overweight” rating in a research report on Friday, July 28th. StockNews.com initiated coverage on Integer in a research report on Thursday, October 5th. They issued a “hold” rating on the stock. Finally, Benchmark boosted their price objective on Integer from $90.00 to $105.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $93.83.

Integer Price Performance

NYSE:ITGR opened at $89.57 on Tuesday. The company has a current ratio of 3.00, a quick ratio of 1.86 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $2.99 billion, a P/E ratio of 36.56, a P/E/G ratio of 1.22 and a beta of 1.10. Integer Holdings Co. has a 12 month low of $61.85 and a 12 month high of $96.17. The business’s 50-day moving average is $80.36 and its 200 day moving average is $83.17.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.22. Integer had a return on equity of 10.27% and a net margin of 5.30%. The business had revenue of $404.69 million for the quarter, compared to the consensus estimate of $376.70 million. During the same period in the prior year, the business posted $0.95 earnings per share. The company’s quarterly revenue was up 18.1% compared to the same quarter last year. On average, equities research analysts forecast that Integer Holdings Co. will post 4.59 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures.